Skip to main content

Trulieve Cannabis Stock Forecast, Price & News

+0.41 (+1.05 %)
(As of 05/14/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume211,900 shs
Average Volume454,166 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive TCNNF News and Ratings via Email

Sign-up to receive the latest news and ratings for Trulieve Cannabis and its competitors with MarketBeat's FREE daily newsletter.

Trulieve Cannabis logo

About Trulieve Cannabis

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of March 16, 2021, the company operated through 83 dispensaries in the United States. The company is headquartered in Quincy, Florida.


See More Headlines

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Next Earnings Date5/18/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

1.68 out of 5 stars

Medical Sector

320th out of 2,044 stocks

Drug Manufacturers - Specialty & Generic Industry

3rd out of 61 stocks

Analyst Opinion: 4.5Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Trulieve Cannabis (OTCMKTS:TCNNF) Frequently Asked Questions

Is Trulieve Cannabis a buy right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trulieve Cannabis in the last year. There are currently 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Trulieve Cannabis stock.
View analyst ratings for Trulieve Cannabis
or view top-rated stocks.

What stocks does MarketBeat like better than Trulieve Cannabis?

Wall Street analysts have given Trulieve Cannabis a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Trulieve Cannabis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Trulieve Cannabis?

Trulieve Cannabis saw a increase in short interest in April. As of April 15th, there was short interest totaling 158,100 shares, an increase of 58.6% from the March 31st total of 99,700 shares. Based on an average trading volume of 751,000 shares, the days-to-cover ratio is presently 0.2 days.
View Trulieve Cannabis' Short Interest

When is Trulieve Cannabis' next earnings date?

Trulieve Cannabis is scheduled to release its next quarterly earnings announcement on Tuesday, May 18th 2021.
View our earnings forecast for Trulieve Cannabis

How has Trulieve Cannabis' stock been impacted by COVID-19?

Trulieve Cannabis' stock was trading at $7.70 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TCNNF shares have increased by 411.0% and is now trading at $39.3481.
View which stocks have been most impacted by COVID-19

What price target have analysts set for TCNNF?

11 Wall Street analysts have issued twelve-month price targets for Trulieve Cannabis' stock. Their forecasts range from $23.00 to $132.00. On average, they anticipate Trulieve Cannabis' stock price to reach $65.64 in the next year. This suggests a possible upside of 66.8% from the stock's current price.
View analysts' price targets for Trulieve Cannabis
or view top-rated stocks among Wall Street analysts.

Who are Trulieve Cannabis' key executives?

Trulieve Cannabis' management team includes the following people:
  • Ms. Kimberly Rivers, Chair, Pres & CEO (Age 42, Pay $540.31k)
  • Mr. Alex D'Amico, Chief Financial Officer (Age 46, Pay $509.96k)
  • Mr. Eric Raymond Powers III, J.D., Chief Legal Officer (Age 51, Pay $282.44k)
  • Mr. Jason Barry Pernell, Chief Information Officer (Age 43)
  • Ms. Lynn Ricci, Director of Investor Relations & Corp. Communications (Age 54)
  • Ms. Victoria Walker, Director of Marketing & Community Relations (Age 36)
  • Mr. Timothy Morey, Chief Sales Officer (Age 58)
  • Ms. Valda Coryat, Chief Marketing Officer (Age 49)
  • Mr. Steven Ferrell, Director of HR (Age 50)
  • Ms. Ronda Sheffield, Chief HR Officer

Who are some of Trulieve Cannabis' key competitors?

What is Trulieve Cannabis' stock symbol?

Trulieve Cannabis trades on the OTCMKTS under the ticker symbol "TCNNF."

How do I buy shares of Trulieve Cannabis?

Shares of TCNNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trulieve Cannabis' stock price today?

One share of TCNNF stock can currently be purchased for approximately $39.35.

How many employees does Trulieve Cannabis have?

Trulieve Cannabis employs 4,455 workers across the globe.

What is Trulieve Cannabis' official website?

The official website for Trulieve Cannabis is

How can I contact Trulieve Cannabis?

The company can be reached via phone at 850-480-7955.

This page was last updated on 5/15/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.